- Home
- PNST vs RGC Comparison
PNST vs RGC Comparison
Compare PNST & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNST
- RGC
- Stock Information
- Founded
- PNST 2007
- RGC 2014
- Country
- PNST United States
- RGC Hong Kong
- Employees
- PNST N/A
- RGC N/A
- Industry
- PNST Blank Checks
- RGC Medicinal Chemicals and Botanical Products
- Sector
- PNST Finance
- RGC Health Care
- Exchange
- PNST Nasdaq
- RGC Nasdaq
- Market Cap
- PNST 111.5M
- RGC 105.3M
- IPO Year
- PNST N/A
- RGC 2021
- Fundamental
- Price
- PNST $0.90
- RGC $6.13
- Analyst Decision
- PNST Strong Buy
- RGC
- Analyst Count
- PNST 3
- RGC 0
- Target Price
- PNST $4.50
- RGC N/A
- AVG Volume (30 Days)
- PNST 55.4K
- RGC 221.5K
- Earning Date
- PNST 11-26-2024
- RGC 11-29-2024
- Dividend Yield
- PNST N/A
- RGC N/A
- EPS Growth
- PNST N/A
- RGC N/A
- EPS
- PNST N/A
- RGC N/A
- Revenue
- PNST $123,579,000.00
- RGC N/A
- Revenue This Year
- PNST $25.96
- RGC N/A
- Revenue Next Year
- PNST $19.30
- RGC N/A
- P/E Ratio
- PNST N/A
- RGC N/A
- Revenue Growth
- PNST 11.06
- RGC N/A
- 52 Week Low
- PNST $0.56
- RGC $3.03
- 52 Week High
- PNST $16.00
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- PNST 55.67
- RGC 48.30
- Support Level
- PNST $0.83
- RGC $6.08
- Resistance Level
- PNST $1.00
- RGC $6.71
- Average True Range (ATR)
- PNST 0.09
- RGC 1.34
- MACD
- PNST 0.03
- RGC -0.10
- Stochastic Oscillator
- PNST 68.72
- RGC 12.59
About PNST Pinstripes Holdings Inc.
Pinstripes Holdings Inc is an experiential dining and entertainment concept combining exceptional Italian-American cuisine with bowling, bocce, and private events. It owns and operates around 17 restaurants in the USA. The company designs and constructs large-format locations that are each 26,000 to 38,000 square feet of interior space, plus additional outdoor patio space that includes outdoor dining, bocce courts, fire-pits, and decorative fountains.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.